Medscape October 29, 2025
(Reuters) -Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer’s pharmacies across the United States at direct-to-consumer prices.
This marks the first time the drugmaker has provided a retail pick-up option to customers who use the LillyDirect website to order Zepbound, it said.
Self-paying customers can get Zepbound single-dose vials in all approved strengths at Walmart pharmacies, with the lowest dose starting at $349 per month, Lilly said.
The drugmaker has been working on expanding access to Zepbound...
Today's Sponsors
Today's Sponsor